Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Blood Parameter Changes Following Aerobic Exercise in Professional Soccer Players

NCT07826598 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-08-29
Last updated
2026-09-17

Condition(s) studied

Exercise PhysiologyBlood Parameters

Investigational drug(s) / intervention(s)

20-Meter Shuttle Run Test

20-Meter Shuttle Run Test: Participants will perform a progressive 20-meter shuttle run test by running continuously between two lines positioned 20 meters apart in time with prerecorded audio signals. Running speed will progressively increase as the interval between the audio signals decreases. The test will end when the participant fails to reach the designated line before the signal on two consecutive occasions.

Study summary

This study aims to investigate acute changes in serum ferritin, folate, vitamin B12, and parathyroid hormone (PTH) levels following aerobic exercise in professional soccer players. Twenty professional male soccer players will voluntarily participate in the study. Participants will complete a progressive 20-meter shuttle run test. Venous blood samples will be collected immediately before and after the exercise protocol. Pre- to post-exercise changes in each blood parameter will be analyzed to determine the acute physiological responses to aerobic exercise in professional soccer players.

Eligibility

Sex
MALE
Min age
18 Years
Max age
25 Years
Healthy volunteers
Accepted
Inclusion Criteria:- Professional soccer players. * Willing and able to participate in the study procedures. * Provision of informed consent. Exclusion Criteria:- Inability to complete the aerobic exercise protocol. \- Withdrawal from the study or unwillingness to continue participation.

Primary outcome measure(s)

  • Change in Serum Ferritin Concentration From Pre-Exercise to Immediately Post-Exercise — Immediately before exercise and immediately after completion of the 20-meter shuttle run test
    Venous blood samples will be collected immediately before and immediately after the 20-meter shuttle run test. Serum ferritin concentration will be measured in ng/mL. For each participant, the change will be calculated by subtracting the pre-exercise value from the post-exercise value. The group-level outcome will be summarized using the mean change and standard deviation.
  • Change in Serum Folate Concentration From Pre-Exercise to Immediately Post-Exercise — Immediately before exercise and immediately after completion of the 20-meter shuttle run test
    Venous blood samples will be collected immediately before and immediately after the 20-meter shuttle run test. Serum folate concentration will be measured in ng/mL. For each participant, the change will be calculated by subtracting the pre-exercise value from the post-exercise value. The group-level outcome will be summarized using the mean change and standard deviation.
  • Change in Serum Vitamin B12 Concentration From Pre-Exercise to Immediately Post-Exercise — Immediately before exercise and immediately after completion of the 20-meter shuttle run test
    Venous blood samples will be collected immediately before and immediately after the 20-meter shuttle run test. Serum vitamin B12 concentration will be measured in pg/mL. For each participant, the change will be calculated by subtracting the pre-exercise value from the post-exercise value. The group-level outcome will be summarized using the mean change and standard deviation.
  • Change in Serum Parathyroid Hormone Concentration From Pre-Exercise to Immediately Post-Exercise — Immediately before exercise and immediately after completion of the 20-meter shuttle run test
    Venous blood samples will be collected immediately before and immediately after the 20-meter shuttle run test. Serum parathyroid hormone (PTH) concentration will be measured in pg/mL. For each participant, the change will be calculated by subtracting the pre-exercise value from the post-exercise value. The group-level outcome will be summarized using the mean change and standard deviation.

Trial sites (1)

FacilityCityRegionStatus
Exercise Physiology Laboratory, Faculty of Sport Sciences, Karabuk University Karabük Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07826598 on ClinicalTrials.gov ↗ ← All trials in Turkey